Based on recent data, Eupraxia Pharmaceuticals Inc. (EPRX) shows an Average True Range (ATR) of 0.46 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 293.91K, indicating liquidity. These fundamental metrics provide insight into EPRX's underlying financial health and market activity.
| ATR | 0.46 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 293.91K |
| Avg Vol (10 Days) | 183.79K |
Eupraxia Pharmaceuticals Inc. (EPRX) technical indicators as of July 17, 2026: the SMA 20 is -1.9%, SMA 50 at 1.85%, and SMA 200 at 36.33%. The RSI 14 value is 48.91, suggesting its current momentum. These technical analysis signals help assess EPRX's price trends and potential future movements.
| SMA 20 | -1.9% |
| SMA 50 | 1.85% |
| SMA 200 | 36.33% |
| RSI 14 | 48.91 |
Eupraxia Pharmaceuticals Inc. (EPRX) stock performance overview as of July 17, 2026: The 52-week high is $9.32 (currently -12.23% below), and the 52-week low is $4.88 (currently 205.21% above). Over the past year, EPRX's performance is 199.67%, compared to the S&P 500's 5.44% change.
| 52-Week High | 9.32 |
| 52-Week High Chg | -12.23% |
| 52-Week Low | 4.88 |
| 52-Week Low Chg | +205.21% |
| S&P 500 52-Week Chg | 5.44% |
According to market data, Eupraxia Pharmaceuticals Inc. (EPRX) stock's recent performance metrics show that over the last month, EPRX is 43.4%, with a Year-to-Date (YTD) performance of 19.47%. Over the past year, the stock has seen a 199.67% change. These figures summarize EPRX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 7.03 | 7.11 | 8.02 | 9.32 | 9.32 | 9.32 |
| Low | 6.08 | 5.63 | 5.63 | 5.63 | 4.88 | 5.63 |
| Performance | +10.00% | +43.40% | +56.06% | +73.80% | +199.67% | +19.47% |
According to current financial data, EPRX stock's P/E (TTM) ratio is -6.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for EPRX, including P/S (N/A), P/B (2.52), and P/FCF (-6.37), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | EPRX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.12 | -1.22 | -194.02 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 466.98 | 5.98 |
| P/B (TTM) | 2.52 | 0 | 10.72 | 5.35 |
| P/FCF (TTM) | -6.37 | -6.3 | -601.14 | 30.26 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep